Janice Small
Family · Princeton, MENPI 1457724148
Payments from drug & device makers
Across 59 payments — averaging $18.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$329
- Novo Nordisk$172
- GSK$105
- Takeda Pharmaceuticals U.S.A., Inc.$68
- Astellas Pharma US Inc$65
- Otsuka America Pharmaceutical, Inc.$61
- plus $294 from 11 others
What the payments were for
- Food & beverage$1,08099%
- Other$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 14 | $329 |
| Novo Nordisk | 11 | $172 |
| GSK | 7 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Astellas Pharma US Inc | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Alkermes, Inc. | 2 | $45 |
| Sanofi-aventis U.S. LLC | 3 | $45 |
| Pfizer | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $34 |
| Exact Sciences | 2 | $28 |
| Johnson & Johnson | 1 | $21 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Novartis | 1 | $18 |
| AbbVie | 1 | $17 |
| Baxter Healthcare | 1 | $14 |
| AstraZeneca | 1 | $13 |
How this compares
$1,094 in reported general payments places this provider in the 85th percentile of 545 family providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 49 | $62,299 |
| OzempicSemaglutide | 56 | $57,087 |
| TrulicityDulaglutide | 27 | $46,605 |
| JardianceEmpagliflozin | 21 | $34,842 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $32,345 |
| JanuviaSitagliptin Phosphate | 20 | $30,862 |
| MounjaroTirzepatide | 20 | $26,844 |
| RexultiBrexpiprazole | 15 | $20,983 |
| MyrbetriqMirabegron | 15 | $18,851 |
| Breo ElliptaFluticasone/Vilanterol | 27 | $18,406 |
| LinzessLinaclotide | 18 | $17,123 |
| Tresiba Flextouch U-200Insulin Degludec | 32 | $16,947 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $14,071 |
| Pregabalin | 88 | $6,453 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $4,344 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $40 | $62,29949 claims |
| Novo NordiskOzempic | $172 | $57,08756 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $105 | $50,75050 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $61 | $20,98315 claims |
| Astellas Pharma US IncMyrbetriq | $65 | $18,85115 claims |
| AbbVieLinzess | $17 | $17,12318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 545 family providers in Maine.
Other family in Princeton
- Michael SwopePrinceton$2K
- Phylicia BonavidaPrinceton$2K
- Tara DwelleyPrinceton$2K
- Mia RapollaFalmouth$193K
- Patti DupreyKennebunk$35K
- Mohamed FarahLewiston$28K
- Amanda WilliamsPortland$8K
- Jamie PiacentiniScarborough$6K
- Patricia HamiltonBangor$6K
- Rosemary PainePortland$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.